BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,600 shares, an increase of 60.0% from the October 31st total of 1,000 shares. Based on an average daily volume of 8,300 shares, the days-to-cover ratio is currently 0.2 days.
BioNxt Solutions Trading Up 5.4 %
OTCMKTS BNXTF opened at $0.19 on Friday. BioNxt Solutions has a fifty-two week low of $0.11 and a fifty-two week high of $0.57. The stock has a 50-day simple moving average of $0.18 and a two-hundred day simple moving average of $0.20.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its earnings results on Wednesday, August 28th. The company reported ($0.01) earnings per share for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Read More
- Five stocks we like better than BioNxt Solutions
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Sentiment Analysis: How it Works
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.